Abstract: A method of manufacturing a composite material through a wet compression molding (WCM) process is disclosed. The internal pressure of a mold is controlled so that productivity may be improved due to process automation through application of a resin using a robot. Quality of the composite material may be improved due to minimization of deformation of a foam core through control of the internal pressure of the mold.

Abstract: Provided are a coronavirus spike (S) protein-specific antibody and use thereof.

Abstract: The present disclosure provides a construction structure corrosion measurement sensor having accuracy higher than that of conventional sensors, and a method for measuring corrosion by using the same. To this end, the present disclosure provides a sensor assembly including an eddy-current sensor including an insulator a coil surrounding the outer periphery of the insulator. The present disclosure also provides a construction structure corrosion measurement method including the steps of: positioning a sensor assembly next to a rebar inside a construction structure in parallel with and adjacent to the rebar; applying a voltage to the sensor assembly; measuring a voltage generated by an eddy current resulting from the adjacent rebar; and conducting measurement at a predetermined time interval so as to measure a voltage change.

Abstract: An electronic device includes a processor, and a memory. The memory may store instructions that, cause the processor to display a user interface including items, receive a first user utterance while the user interface is displayed, wherein the first user utterance includes a first request for executing a first task by using at least one item, transmit first data related to the first user utterance to an external server, receive a first response from the external server, wherein the first response includes information on a first sequence of states of the electronic device for executing the first task and further includes numbers and locations of the items in the user interface, and execute the first task including an operation of allowing the application program to select the one or the plurality of items based on the numbers or the locations.

Abstract: The present disclosure provides a construction structure corrosion measurement sensor having accuracy higher than that of conventional sensors, and a method for measuring corrosion by using the same. To this end, the present disclosure provides a sensor assembly including an eddy-current sensor including an insulator a coil surrounding the outer periphery of the insulator. The present disclosure also provides a construction structure corrosion measurement method including the steps of: positioning a sensor assembly next to a rebar inside a construction structure in parallel with and adjacent to the rebar; applying a voltage to the sensor assembly; measuring a voltage generated by an eddy current resulting from the adjacent rebar; and conducting measurement at a predetermined time interval so as to measure a voltage change.

Abstract: A method, apparatus, and system for paying are provided. The method for paying of an electronic device includes: receiving item order information from a POS terminal; determining a payment method by considering at least one of a discount benefit and a reward point saving benefit based on the received item order information; and requesting a payment approval for the item order information in the determined payment method.

Abstract: An electronic device includes a processor, and a memory. The memory may store instructions that, cause the processor to display a user interface including items, receive a first user utterance while the user interface is displayed, wherein the first user utterance includes a first request for executing a first task by using at least one item, transmit first data related to the first user utterance to an external server, receive a first response from the external server, wherein the first response includes information on a first sequence of states of the electronic device for executing the first task and further includes numbers and locations of the items in the user interface, and execute the first task including an operation of allowing the application program to select the one or the plurality of items based on the numbers or the locations.

Abstract: The present invention relates to a method for screening for a cancer treatment agent by contacting a test material with pancreatic adenocarcinoma upregulated factor (PAUF) and GLRX3, SNAPIN, or UBL4A, as a binding partner for PAUF, and then analyzing whether or not the test material inhibits the binding of the PAUF and GLRX3, SNAPIN, or UBL4A serving as a binding partner therefor, thereby determining that the test material is a cancer treatment agent if the binding is inhibited. The invention also relates to a pharmaceutical composition containing the test material as an active ingredient for inhibiting and treating cancer. The pharmaceutical composition of the present invention, which contains, as an active ingredient, an inhibitor for inhibiting PAUF from binding with a binding partner, effectively inhibits PAUF signaling related to the onset of cancer, thus enabling various kinds of cancer (especially pancreatic cancer) to be treated.

Abstract: The present invention provides a novel molecule marker for resistance to an anticancer agent for biliary tract cancer, and diagnostic and therapeutic uses thereof. The marker, according to the present invention, shows significantly increased expression in an anticancer agent-resistant biliary tract cancer cell line compared to a non-anticancer agent-resistant biliary tract cancer cell line. By inhibiting the expression of protein in the marker according to the present invention, sensitivity of anticancer agent-resistant biliary tract cancer to the anticancer agent can be increased.

Abstract: An electronic device includes a display, a local wireless communication circuit, a memory, a payment application, and a processor. The memory is configured to store a financial application. The processor is configured to launch the financial application. The processor is also configured to output account information of a user and a graphic user interface (GUI) object associated with the account information on the display. The processor is also configured to launch the payment application in response to selecting the GUI object. The processor is also configured to transmit data of a card linked to the account information to an external device via the local wireless communication circuit.

Abstract: A method, apparatus, and system for paying are provided. The method for paying of an electronic device includes: receiving item order information from a POS terminal; determining a payment method by considering at least one of a discount benefit and a reward point saving benefit based on the received item order information; and requesting a payment approval for the item order information in the determined payment method.

Abstract: An electronic device and a method for supporting a payment function are disclosed. The electronic device includes a communication module, at least one memory configured to store a payment application and payment information relating to the payment application, and a processor, wherein the memory stores instructions that, when executed, cause the processor to receive the payment information from an external device via the communication module and store the received payment information in the memory, receive a stop or deactivation request of the payment application and/or the payment information from the external device via the communication module, and in response to the request, stop or deactivate the payment application and/or the payment information.

Abstract: The present invention relates to a method for screening for a cancer treatment agent by contacting a test material with pancreatic adenocarcinoma upregulated factor (PAUF) and GLRX3, SNAPIN, or UBL4A, as a binding partner for PAUF, and then analyzing whether or not the test material inhibits the binding of the PAUF and GLRX3, SNAPIN, or UBL4A serving as a binding partner therefor, thereby determining that the test material is a cancer treatment agent if the binding is inhibited. The invention also relates to a pharmaceutical composition containing the test material as an active ingredient for inhibiting and treating cancer. The pharmaceutical composition of the present invention, which contains, as an active ingredient, an inhibitor for inhibiting PAUF from binding with a binding partner, effectively inhibits PAUF signaling related to the onset of cancer, thus enabling various kinds of cancer (especially pancreatic cancer) to be treated.